| scholarly article | Q13442814 |
| P2093 | author name string | Aviram M | |
| Bomzon A | |||
| Ljubuncic P | |||
| Fuhrman B | |||
| Oiknine J | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration | Q28334026 | ||
| Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide | Q29547245 | ||
| Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium | Q34109467 | ||
| Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment | Q34532076 | ||
| Mechanism of bile acid-induced HCO3-(-)rich hypercholeresis. An analysis based on quantitative acid-base chemistry | Q36767100 | ||
| Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis | Q39514969 | ||
| Current concepts: immunology. Monocytes and macrophages | Q39631972 | ||
| Biology of disease: free radicals and tissue injury | Q40131504 | ||
| Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children | Q40457634 | ||
| Liver cell necrosis: cellular mechanisms and clinical implications | Q40560137 | ||
| Pharmacology of ursodeoxycholic acid, an enterohepatic drug. | Q40571618 | ||
| Measuring free radical reactions in vivo | Q40771849 | ||
| The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells | Q41544971 | ||
| Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis | Q42280172 | ||
| Ursodeoxycholic acid and primary biliary cirrhosis | Q42699503 | ||
| Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. | Q44951192 | ||
| Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions | Q45041992 | ||
| Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. | Q45089631 | ||
| Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids. | Q46037146 | ||
| Hepatic injury induced by bile salts: correlation between biochemical and morphological events | Q46245057 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. | Q50768235 | ||
| Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. | Q50783106 | ||
| Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. | Q51597193 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis | Q68166227 | ||
| Immunomodulatory effects of ursodeoxycholic acid on immune responses | Q68225187 | ||
| Malondialdehyde determination as index of lipid peroxidation | Q68592283 | ||
| Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinase C1 | Q69243869 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Molecular aspects of membrane stabilization by ursodeoxycholate [see comment] | Q70457384 | ||
| Hepatoprotective properties of ursodeoxycholic acid | Q70734314 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection | Q72538438 | ||
| Ursodeoxycholate-induced hypercholeresis in cirrhotic rats: further evidence for cholehepatic shunting | Q72719782 | ||
| Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria | Q72862935 | ||
| Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing | Q72963639 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 475-478 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages | |
| P478 | volume | 39 |
| Q44982548 | A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation |
| Q46827714 | A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis |
| Q38223869 | ALSUntangled no. 25: ursodiol |
| Q44214673 | Antioxidant properties of ursodeoxycholic acid. |
| Q45139514 | Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats. |
| Q36343844 | Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers |
| Q37157813 | Bile-acid-induced cell injury and protection |
| Q35358467 | Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment |
| Q45133783 | Cholemic transgenic mice: a novel animal model to investigate the effects of bile acids |
| Q44924200 | Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet |
| Q39424431 | Circulating oxidative stress status in desert sheep naturally infected with Fasciola hepatica |
| Q45831797 | Coenzyme Q in pregnant women and rats with intrahepatic cholestasis |
| Q47359239 | Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease |
| Q44208460 | Ebselen protects against the reduction in levels of drug-metabolizing enzymes in livers of rats with deoxycholic acid-induced liver injury |
| Q74760853 | Effect of bile acids on lipid peroxidation: the role of iron |
| Q33195833 | Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines |
| Q44028461 | Effects of bile acids on the muscle functions of guinea pig gallbladder |
| Q54458077 | Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats. |
| Q62072028 | Enhanced bile formation induced by experimental dicrocoeliosis in the hamster |
| Q42098000 | Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease |
| Q39388510 | Galectin-3 regulates inflammasome activation in cholestatic liver injury |
| Q41139594 | Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. |
| Q34480726 | LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants |
| Q41071344 | Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies |
| Q40977802 | Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL. |
| Q33591454 | Mechanism of hepatoprotective action of bile salts in liver disease |
| Q43705251 | Melatonin protects against renal oxidative stress after obstructive jaundice in rats |
| Q33182216 | Micronuclei induction, cell cycle delay and apoptosis as markers of cellular stress caused by ursodeoxycholic acid in human lymphocytes. |
| Q90416246 | Nonalcoholic Fatty Liver Disease |
| Q43264519 | On the in vitro vasoactivity of bile acids |
| Q44360006 | Oxidant stress is a significant feature of primary biliary cirrhosis. |
| Q34342998 | Oxidative stress and vascular smooth muscle cell function in liver disease |
| Q26853520 | Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy |
| Q50519449 | Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids. |
| Q54473301 | Role of macrophages in bile acid-induced inflammatory response of fetal lung during maternal cholestasis. |
| Q39229508 | Role of oxidative stress in concomitant occurrence of Fasciola gigantica and leiomyoma in cattle. |
| Q79556893 | T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis |
| Q73144078 | The cytotoxic effects of bile acids in crude bile on human pancreatic cancer cell lines |
| Q44590451 | The effect of endoscopic retrograde cholangiopancreatography on the serum IL-18 and erythrocytes antioxidative capacity in biliary obstructive jaundice. |
| Q47792574 | The effects of Bile Acids on Freshly Isolated Rat Glomeruli and Proximal Tubular Fragments |
| Q74523422 | The role of ursodeoxycholic acid in bile acid-mediated kidney fragment toxicity |
| Q45957539 | Time-related alterations of superoxide radical levels in diverse organs of bile duct-ligated rats. |
| Q38058982 | Treatment of NASH with ursodeoxycholic acid: pro. |
| Q43893607 | Unconjugated bile acids modulate adult and neonatal neutrophil chemotaxis induced in vitro by N-formyl-met-leu-phe-peptide |
| Q37617217 | Ursodeoxycholic Acid ameliorates pain severity and cartilage degeneration in monosodium iodoacetate-induced osteoarthritis in rats |
| Q43749582 | Ursodeoxycholic acid and in vitro vasoactivity of hydrophobic bile acids |
| Q39677430 | Ursodeoxycholic acid and superoxide anion |
| Q28379482 | Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production |
| Q34139873 | Ursodeoxycholic acid prevents selenite-induced oxidative stress and alleviates cataract formation: In vitro and in vivo studies. |
| Q31704415 | Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease |
| Q42559189 | Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed |
Search more.